Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Jay S. Skyler's publication output changed over time?
ScholarIQpublication output · 2004–2021
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2021.
1
1
2
1
1
1
1
1
1
1
2004200820092011201520162018201920202021
What are the most-cited papers on Jay S. Skyler?
ScholarIQmost cited works
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
Diabetes Care. 20151,174 CitationsOPEN ACCESS
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
New England Journal of Medicine. 20191,141 CitationsOPEN ACCESS
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler
New England Journal of Medicine. 20091,079 CitationsOPEN ACCESS
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R. Bornstein, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L. Birkenfeld, Bernhard O. Boehm, Stephanie A. Amiel, Richard I. G. Holt, Jay S. Skyler, J. Hans DeVries, Éric Renard, Robert H. Eckel, Paul Zimmet, K. G. M. M. Alberti, Josép Vidal, Bruno Geloneze, Juliana C.N. Chan, Linong Ji, Barbara Ludwig
The Lancet Diabetes & Endocrinology. 2020995 CitationsOPEN ACCESS
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, Prakash Deedwania, Edwin Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven, Robert S. Sherwin
Diabetes Care. 2008886 CitationsOPEN ACCESS
Related on ScholarIQ
University of Miami
Institution
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Paper
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Paper
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Paper
Practical recommendations for the management of diabetes in patients with COVID-19
Paper
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Paper